Merck KGaA [Rocket]

Date	Name	Type	Security	Shares	Price	Value	Ownership	Reported
10/26/2021	Xilio Therapeutics, Inc.	Conversion	Series C Preferred Srock	2.5M	$0.00	$0	See Footnote	10/26/2021
10/26/2021	Xilio Therapeutics, Inc.	Conversion	Series B Preferred Stock	4M	$0.00	$0	See Footnote	10/26/2021
10/26/2021	Xilio Therapeutics, Inc.	Conversion	Common Stock	264.8k	$0.00	$0	See Footnote	10/26/2021
10/26/2021	Xilio Therapeutics, Inc.	Conversion	Common Stock	416.1k	$0.00	$0	See Footnote	10/26/2021